Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01872936 Org: User:
Start: 06/30/13 End: 01/31/15 Due: 01/31/16

Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH

Phase: N/A Priority: Normal
NCT ID: NCT01350960 Org: User:
Start: 05/31/11 End: 11/30/11 Due: 11/30/12

Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01727934 Org: User:
Start: 11/30/12 End: 04/30/14 Due: 04/30/15

SPC2996 in Chronic Lymphocytic Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT00285103 Org: User:
Start: 06/30/05 End: 12/31/07 Due: 12/31/08

Multiple Ascending Dose Study of SPC4955 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01365663 Org: User:
Start: 05/31/11 End: 11/30/11 Due: 11/30/12

Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01200420 Org: User:
Start: 09/30/10 End: 12/31/11 Due: 12/31/12

Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01646489 Org: User:
Start: 06/30/12 End: 09/30/12 Due: 09/30/13

Safety Study of SPC3649 in Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT00688012 Org: User:
Start: 05/31/08 End: 05/31/09 Due: 05/31/10

SPC3649 Multiple Dose Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00979927 Org: User:
Start: 09/30/09 End: 09/30/10 Due: 09/30/11